AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05387057 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exergame training according to the 'Brain-IT' exergame-based training concept
Description: For an overview, our 'Brain-IT' exergame-based training concept consists of an individually adapted multi-domain exergame-based simultaneous cognitive-motor training with incorporated cognitive tasks that will be adopted with a deficit-oriented focus on the neurocognitive domains of (1) learning and memory, (2) executive function, (3) complex attention, and (4) visuospatial skills. According to the training concept, each participant is instructed to train 5x/week for 24 min per session resulting in a weekly exercise volume of 120 min. All training sessions are planned to take place at participant's homes using the exergame training system 'Senso Flex' (Dividat AG, Schindellegi, Switzerland). For a detailed description of the complete 'Brain-IT' exergame-based training concept with sufficient details to allow full replication, consider our methodological paper (doi: 10.3389/fnagi.2021.734012).
Study NCT05387057 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: The control group will proceed with usual care as provided by the (memory) clinics where the patients are recruited.
Study NCT05088668 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented reality
Description: The subjects will perform scapular repositioning exercise using glasses of augmented reality to see their scapular movement simultaneously. Furthermore, they will also see at the same time a video record of an ideal scapular movement, and will me encouraged to simulate that ideal scapular movement.
Study NCT05088668 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular repositioning exercise
Description: Subjects will perform scapular repositioning exercises for improving scapular movement.
Study NCT05088668 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Scapular repositioning exercise
Description: Subjects will perform scapular repositioning exercises for improving scapular movement.
Study NCT06504186 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Blinatumomab
Description: * Ph-negative B-ALL: bephedolumab (≥ 45 kg: 9 mcg/d D1-2, 28 mcg/d D3-14 or 28 mcg/d D1-14; \< 45 kg: 5 mg/m2/d D1-2, 15 mg/m2/d D3-14) in 28-day cycles for 3 cycles.~* Ph-positive B-ALL: treatment with bephytoin + TKIs, bephytoin (≥ 45 kg: 9 mcg/d D1-2, 28 mcg/d D3-14 or 28 mcg/d D1-14; \< 45 kg: 5 mg/m2/d D1-2, 15 mg/m2/d D3-14) in 28-day cycles for 3 cycles.
Study NCT06502938 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pan-vascular interventional robotic system
Description: Pan-vascular interventional robotic system assited PCI for delivery and manipulation of guidewires, catheters, and quick exchange balloon dilatation catheters/stents.
Study NCT06502938 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Traditional artificial percutaneous coronary intervention
Description: Doctors perform traditional percutaneous coronary intervention
Study NCT06001619 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prostate hyperplasia medication
Description: The dosages prostatic hyperplasia medication: dutasteride 0,5 MG x1 or finasteride 5 MG x1 or combination of dutasteride and tamsulosin 0,5/0,4 MG x1.
Study NCT06001619 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LhRH-antagonist
Description: The starting dose in prostatic cancer patient cohort of LHRH antagonist degarelix is 120 MGx2 and the maintenance dose is 80 MGx1.
Study NCT05367128 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dual task training
Description: All participants will receive cognitive dual task training for 30 min/session, 2-3 sessions/week for 4-6 weeks (a total of 12 sessions). The cognitive dual task training includes 15 min of cognitive task combining with standing task and 15 min of cognitive task combining with walking task. The differences among group are the instructions of task prioritization given by the therapist
Study NCT05367128 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dual task training
Description: All participants will receive cognitive dual task training for 30 min/session, 2-3 sessions/week for 4-6 weeks (a total of 12 sessions). The cognitive dual task training includes 15 min of cognitive task combining with standing task and 15 min of cognitive task combining with walking task. The differences among group are the instructions of task prioritization given by the therapist
Study NCT06359912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EPCs
Description: IV
Study NCT06359912 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinical standard treatment (CST)
Description: Clinical standard treatment
Study NCT06359912 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Clinical standard treatment (CST)
Description: Clinical standard treatment
Study NCT06582342 — intervention group
Intervention type: PROCEDURE
Intervention: Three dimensional imaging technology (3D-PANC MSP model)
Description: The processing of the CT images obtained in each center for the creation of the 3D model will be performed centrally by the team of radiologists and computer scientists of the company Cella Medical Solutions. This team will be blinded to the reports of the CT scans.For each patient 4 NCCN check-lists will be filled in without knowing the result of the surgery or the AP study: 2 based on the conventional CT and two based on the 3D-MSP study.
Study NCT06582342 — intervention group
Intervention type: PROCEDURE
Intervention: Computerized tomography group (conventional CT)
Description: A multiphase CT (venous phase and pancreatographic phase) with 1mm thick slices and series of images in coronal, axial and sagittal reconstructions will be performed. This CT model will be performed at disease diagnosis and after completion of neoadjuvant chemotherapy treatment. Both CT scans will be independently reported by a radiologist from the hospital of origin. The preoperative CT scan will also be evaluated a posteriori by a radiologist from the sponsoring center with expertise in PAC. Both reports (the one from the radiologist of the center and the one from the radiologist of the sponsoring center) will be used to fill out the imaging study variables sheet based on the latest version of the NCCN 2022 guidelines. The radiologists will not know the outcome of the surgery or the anatomic pathology study at the time of the completion of the report.
Study NCT05783232 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 1 Capsules
Description: Participants will use their Placebo Control Form 1 Capsules as directed for a period of 4 weeks.
Study NCT05783232 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Health Active Study Product 1.1 Capsules
Description: Participants will use their Radicle Health Active Study Product 1.1 Capsules as directed for a period of 4 weeks.
Study NCT05783232 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Health Active Study Product 1.2 Capsules
Description: Participants will use their Radicle Health Active Study Product 1.2 Capsules as directed for a period of 4 weeks.
Study NCT05783232 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Health Active Study Product 1.3 Capsules
Description: Participants will use their Radicle Health Active Study Product 1.3 Capsules as directed for a period of 4 weeks.
Study NCT04700137 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Caring Contacts Plus Introductory Phone Call (CC+)
Description: One introductory semi-structured caring phone conversation with a follow-up specialist to check-in, establish a personal connection, and provide resources at the 0-2 week time-point followed by 11 non-demanding, caring text or email messages sent over the course of 6 months.
Study NCT04700137 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Caring Contacts without an introductory phone call (CC)
Description: Eleven non-demanding, caring text or email messages sent over the course of 6 months. Participants will not know or have spoken to the follow-up specialist who sends the caring messages.
Study NCT04587999 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bladder stimulation
Description: The bladder stimulation technique requires the presence of 2 people:~* The child must be held by an adult (caregiver or parent) under the armpits, legs dangling.~* the first person (the investigator), performs the stimulation technique consisting of: rapid tapping (frequency of about 100 / min), over the pubic area, at the level of the bladder, alternated with external rotational movements of the pits lumbar, in the kidneys. Alternate these 2 maneuvers every 30 seconds.~* The second person starts the stopwatch at the start of the stimulation, and is about to collect the urine, 2nd jet in a sterile pot~* The maneuver ends as soon as urine is obtained, and will be stopped after 5 minutes in case of failure.
Study NCT04587999 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quick wee
Description: The Quick wee technique requires the presence of only one person:~Stimulation of the suprapubic area by circular movements, with a cold and wet compress held by sterile forceps.~Collection of urine in a sterile container.
Study NCT05478252 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide J
Description: Participants will initially receive 0.25 mg subcutaneous injections of semaglutide J OW and the dose will be then escalated once in 4 weeks for 8 weeks until the target maintenance dose of 1.0 mg is reached which will be maintained for a period of 20 weeks: 0.25 mg (week 1 to week 4), 0.5 mg (week 5 to week 8), 1.0 mg (week 9 to week 28).
Study NCT05478252 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Semaglutide B
Description: Participants will initially receive 0.25 mg subcutaneous injections of semaglutide B OW and the dose will be then escalated once in 4 weeks for 8 weeks until the target maintenance dose of 1.0 mg is reached which will be maintained for a period of 20 weeks: 0.25 mg (week 1 to week 4), 0.5 mg (week 5 to week 8), 1.0 mg (week 9 to week 28).
Study NCT04884373 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Gastric ultrasound
Description: An ultrasound exam will be performed before induction of anaesthesia. GUS results from selected patients will be systematically acquired and assessed following an algorithm (Appendix Ia). The ultrasound results will be collected on a standardized form (Appendix IIa). The technique is performed in the supine and right lateral decubitus position (Appendix Ib) and only by anesthesiologists with sufficient experience with ultrasound and the technique. The patient will be asked to indicate his/her satiety on a predetermined ten-point scale.
Study NCT04663230 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: cardiac magnetic resonance imaging
Description: right atrial late gadolinium enhancement in % and cm2
Study NCT06363656 — intervention group
Intervention type: DEVICE
Intervention: Wears the smartwatch during the sleep time to capture sleep characteristics and answer questionaires
Description: * Synchronization of smartwatch with smartphone (internet connection) to send sleep characteristics captured by the application~* Weight~* Height~* Body measurements (circumferences)~* Questionnaires about overall health status~* Pittsburgh Sleep Quality Index questionnaire~* Insomnia Severity Index~* Sleep Hygiene Index~* Epworth Sleepiness Scale~* NoSAS score (Neck, Obesity, Snoring, Age, Sex)
Study NCT06089512 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: paravertebral block group
Description: Paravertebral block was applied to the patients after induction of general anesthesia; Intraoperative opioid requirement and postoperative pain scores and analgesic requirement were evaluated.
Study NCT06089512 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mid point transverse process block group
Description: Mid point transverse process block was applied to the patients after induction of general anesthesia; Intraoperative opioid requirement and postoperative pain scores and analgesic requirement were evaluated.
Study NCT06089512 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: Only general anesthesia was applied to the patients.
Study NCT06364904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab, Cisplatin, Gemcitabine and Trilaciclib
Description: Chemoimmunotherapy:~1. Tislelizumab: 200mg, 1x time at d1 each cycle~2. Gemcitabine: 1000mg/ m2, in d1, d8 each cycle~3. Cisplatin: 70 mg/m2, in d2 each cycle~4. Trilaciclib: 240mg/m2, d1, d2, d8 each cycle~Tislelizumab maintenance therapy: after chemoimmunotherapy, 200mg, q3W.
Study NCT06364904 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tislelizumab, Cisplatin, Gemcitabine
Description: Chemoimmunotherapy:~1. Tislelizumab: 200mg, 1x time at d1 each cycle~2. Gemcitabine: 1000mg/ m2, in d1, d8 each cycle~3. Cisplatin: 70 mg/m2, in d2 each cycle~Tislelizumab maintenance therapy: after chemoimmunotherapy, 200mg, q3W.
Study NCT05215301 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Multidimensional Voice Program
Description: MDVP (Multidimensional Voice Program) is a computerized acoustic analysis used to analyze sound quality using various parameters. Multidimensional Voice Program (MDVP) 4500 produced by Kay Elemetric Corp was used for voice evaluation.~Research subjects were asked to make a vowel sound /a/ using the same tone and intensity as the subject's daily speech. The researcher will give an example before letting the research subject tries. Voice recording was done using a microphone connected to a computer with the MDVP program. Voice recording was done in a quiet room for at least 3 seconds with a microphone distance of 10 cm from the mouth of the research subject. The recorded sound will be directly analyzed with the MDVP program. Sound recording was done 3 - 5 times, and the best sound acoustic analysis results were used for the study.
Study NCT04766554 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter) and protocol-based interventions
Description: In the intervention group, an alarm threshold below 15% of the baseline rSO2 value will be established. Based on the predetermined algorithm the rSO2 will be maintained at or above 85% of the baseline measurements. If the rSO2 reaches levels below 15% of the baseline values or below 50% in absolute value for over 30 seconds, protocol-based interventions will be performed to restore rSO2 to baseline levels.
Study NCT05239273 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Complex Decongestive Therapy
Description: Phase 1 of CDT will be applied. This application consists of manual lymph drainage, skin care, compression bandage and exercises.
Study NCT05239273 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: No intervention
Study NCT04838509 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: retrospective descriptive without intervention
Study NCT05093842 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sedentary Behavior Reduction
Description: Participants receive bimonthly behavioral health coaching, a sit-stand desk attachment or table, and an activity prompter if they do not already have one (e.g., fitbit, as needed).
Study NCT05093842 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Information on Physical Activity Recommendations during Pregnancy
Description: Participants in the study will receive educational materials provided one time by email about the currently recommended physical activity during pregnancy.
Study NCT05093842 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Information on Physical Activity Recommendations during Pregnancy
Description: Participants in the study will receive educational materials provided one time by email about the currently recommended physical activity during pregnancy.
Study NCT05139550 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smartphone Rehabilitation Application
Description: Upper Limb Exercise Protocol:~Passive Exercises~ROMs for shoulder, ROMs for elbow, ROMs for wrist,fingers and thumb~Active/Assisted Exercises~bilateral shoulder flexion with both hands interlocked, Elbow pronation and supination, Wrist flexion and extension with the help of unaffected hand, Forearm to box, Extend elbow (side), Hand to box (front)~Functional Activities~Lift can, Lift pencil, Lift paper clip, Stack checkers,Flip cards, Fold towel, drinking water from a glass, lifting a glass of water to a level of 90° shoulder flexion with an extended elbow, moving 5 crystals from the table to a box, wiping the table with a towel with the elbow extended, grasping and releasing a 6 cm in diameter tennis ball, combing their hair, Eating with affected hand, opening and closing jars
Study NCT04720027 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Duplex imaging
Description: Completion of AVVQ and EQ5D questionnairs
Study NCT05414422 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCN-101
Description: Concentrate for solution for infusion
Study NCT05414422 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Concentrate for solution for infusion
Study NCT06073470 — intervention group
Intervention type: DRUG
Intervention: methylphenidate
Description: The patients with ADHD will receive 12-week treatment with methylphenidate.
Study NCT06275802 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Education
Description: Nutrition interventions consisting of 8 modules (powerpoint supported classroom lesson, video demonstration, role-play, healthy plate model game, poster preparation, bookmarks, refrigerator magnets, etc. preparation of reminder messages, competitions such as slogan-painting contest, activities such as sports and nutrition festival).
Study NCT06275802 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: nutritional status, eating habits
Description: At the beginning of the study (June 2022), an introductory form (sociodemographic characteristics, body image (Stunkart scale), dietary habits, knowledge about weight status) was applied to all students. Adolescent Nutrition Literacy Scale (ANLS), Instrument of Nutrition Literacy, Mediterranean Diet Quality Index (KID-MED), Eating Attitudes Test 26 (EAT-26), International Physical Activity Questionnaire Short Form (IPAQ) were applied, anthropometric measurements and three-day food consumption records were taken
Study NCT06275802 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: nutritional status, eating habits
Description: At the beginning of the study (June 2022), an introductory form (sociodemographic characteristics, body image (Stunkart scale), dietary habits, knowledge about weight status) was applied to all students. Adolescent Nutrition Literacy Scale (ANLS), Instrument of Nutrition Literacy, Mediterranean Diet Quality Index (KID-MED), Eating Attitudes Test 26 (EAT-26), International Physical Activity Questionnaire Short Form (IPAQ) were applied, anthropometric measurements and three-day food consumption records were taken
Study NCT06171646 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: breathing exercise
Description: The patients in the intervention group will first be informed by the researcher about pursed lips and diaphragmatic breathing exercises through a face-to-face interview technique, and then the breathing exercises will be taught practically to each patient for approximately 30 minutes, and the first session will be held. Each session takes place once a day in the morning, lasts 10-15 minutes and is applied every day; Sessions other than the first session will consist of 10 pursed lip breathing exercises, relaxation (2 minutes) and 10 diaphragmatic breathing exercises; Three days a week, the researcher will be reminded via online video call once a day in the morning, and on the other days, the patients will be reminded by phone call that they will be asked to do themselves, and breathing exercises will be performed for a total of four weeks.
Study NCT04458415 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traxi Panniculus Retractor (TPR)
Description: Surgeon uses the Traxi Panniculus Retractor (TPR) surgical retraction device to retract the panniculus during C-Section.
Study NCT04458415 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Silk Tape
Description: Surgeon uses silk tape to retract the panniculus during C-Section.
Study NCT05626127 — intervention group
Intervention type: OTHER
Intervention: No interventions
Description: As this is a observational study, there are no interventions.
Study NCT06128122 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intrarticular and subcutaneous dextrose injection with timed measurement of dextrose levels
Description: Step one: 30 mL of 12.5%/0.1% lidocaine will be injected into the knee using an inferomedial approach. Using ultrasound guidance, a 20-gauge 2-inch I.V. catheter will be placed in the suprapatellar pouch, by which samples of synovial fluid from the pouch will be withdrawn and analyzed for glucose level.~Step two: 3 mL of D5W will be injected into a marked spot on the back of the upper arm. A sensor/transmitter (Dexcom G7 Dexcom) is placed at the site of injection. The sensor/transmitter will begin providing dextrose levels at 5 minute intervals beginning one-half hour after placement of the sensor/transmitter, transmitted to a paired smart phone.
Study NCT05308927 — intervention group
Intervention type: DRUG
Intervention: Norditropin
Description: Patients will be treated with commercially available Norditropin® according to routine clinical practice at the discretion of the treating physician.
Study NCT06392269 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Tasso+SST
Description: Clinical evaluation of capillary blood samples collected using the Tasso+SST device for downstream analyte testing.
Study NCT05256667 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: RCT-SV
Description: Group 1- Endodontic treatment in a single visit using chemomechanical preparation and passive ultrasonic irrigation, followed by obturation and final restoration.